SCHEMBL6750240

SCHEMBL6750240

COc1ccc([C](c2ccc(OC)cc2)c2cccc3ccccc23)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.54
NPC1 O15118 4/20 0.54
KMT2A Q03164 3/20 0.54
GCGR P47871 1/20 0.50
CNR1 P21554 2/20 0.48
CNR2 P34972 2/20 0.48
CACNA1B Q00975 1/20 0.48
APBA1 Q02410 1/20 0.48
ALDH1A1 P00352 2/20 0.47
POLB P06746 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
HSP90AA1 P07900 1/20 0.45
HSP90AB1 P08238 1/20 0.45
MAPT P10636 2/20 0.44
CES2 O00748 1/20 0.44
CES1 P23141 1/20 0.44
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
HPGD P15428 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL383491 0.97 RAB9A (0.51) RAB9ANPC1KMT2AGCGRCNR1
SCHEMBL9856912 0.83 GCGR (0.67) RAB9ANPC1KMT2AGCGRCNR1
SCHEMBL16549911 0.83 RAB9A (0.51) RAB9ANPC1KMT2AGCGRCNR1
SCHEMBL16538302 0.81 MGLL (0.50) RAB9ANPC1KMT2AGCGRCNR1
SCHEMBL16538303 0.81 MGLL (0.50) RAB9ANPC1KMT2AGCGRCNR1
SCHEMBL40515 0.79 NR4A1 (0.59) RAB9ANPC1KMT2ACNR2ALDH1A1
SCHEMBL40667 0.79 KMT2A (0.41) RAB9ANPC1KMT2AALDH1A1POLB
SCHEMBL28813458 0.77 CACNA1B (0.59) RAB9ANPC1KMT2ACNR1CNR2
SCHEMBL1176798 0.76 NPC1 (0.51) RAB9ANPC1KMT2AGCGRCNR1
SCHEMBL9707076 0.75 NPC1 (0.50) RAB9ANPC1KMT2AGCGRCNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142946-A1 Modified nucleosides and nucleotides and use thereof CHATTOPADHYAYA JYOTI (SE) 2004-07-22 US claimed
US-5721350-A Deuterated nucleosides CHATTOPADHYAYA JYOTI (SE) 1998-02-24 US claimed
EP-0648220-A1 DEUTERATED NUCLEOSIDES CHATTOPADHYAYA, Jyoti (SE) 1995-04-19 EP claimed
WO-1993025566-A1 DEUTERATED NUCLEOSIDES CHATTOPADHYAYA JYOTI (SE) 1993-12-23 WO claimed
US-4973679-A Process for oligonucleo tide synthesis using phosphormidite intermediates UNIVERSITY PATENTS, INC. (US) 1990-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142946-A1 Modified nucleosides and nucleotides and use thereof RNASEH1, RNASEL, NSUN2 RAB9A 2659/4885NPC1 906/4885KMT2A 1336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.